BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28648514)

  • 1. Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors.
    Monte TL; Pereira FS; Reckziegel EDR; Augustin MC; Locks-Coelho LD; Santos ASP; Pedroso JL; Barsottini O; Vargas FR; Saraiva-Pereira ML; Jardim LB;
    Parkinsonism Relat Disord; 2017 Sep; 42():54-60. PubMed ID: 28648514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NESSCA Validation and Responsiveness of Several Rating Scales in Spinocerebellar Ataxia Type 2.
    Monte TL; Reckziegel ER; Augustin MC; Silva ASP; Locks-Coelho LD; Barsottini O; Pedroso JL; Vargas FR; Saraiva-Pereira ML; Leotti VB; Jardim LB;
    Cerebellum; 2017 Aug; 16(4):852-858. PubMed ID: 28456900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population.
    Chen SJ; Lee NC; Chien YH; Hwu WL; Lin CH
    Brain Behav; 2019 Oct; 9(10):e01414. PubMed ID: 31523939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of glutathione S-transferase omega polymorphism and spinocerebellar ataxia type 2.
    Almaguer-Mederos LE; Almaguer-Gotay D; Aguilera-Rodríguez R; González-Zaldívar Y; Cuello-Almarales D; Laffita-Mesa J; Vázquez-Mojena Y; Zayas-Feria P; Rodríguez-Labrada R; Velázquez-Pérez L; MacLeod P
    J Neurol Sci; 2017 Jan; 372():324-328. PubMed ID: 28017238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial complex I gene variant associated with early age at onset in spinocerebellar ataxia type 2.
    Simon DK; Zheng K; Velázquez L; Santos N; Almaguer L; Figueroa KP; Pulst SM
    Arch Neurol; 2007 Jul; 64(7):1042-4. PubMed ID: 17620498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CAG repeats on the age at onset of patients with spinocerebellar ataxia type 2 in China.
    Li Y; Liu Z; Hou X; Chen Z; Shen L; Xia K; Tang B; Jiang H; Wang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):793-799. PubMed ID: 34565721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2.
    Wang C; Xu Y; Feng X; Ma J; Xie S; Zhang Y; Tang BS; Chan P
    Neurobiol Aging; 2015 Jan; 36(1):545.e1-7. PubMed ID: 25189117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATXN3, ATXN7, CACNA1A, and RAI1 Genes and Mitochondrial Polymorphism A10398G Did Not Modify Age at Onset in Spinocerebellar Ataxia Type 2 Patients from South America.
    Pereira FS; Monte TL; Locks-Coelho LD; Silva AS; Barsottini O; Pedroso JL; Cornejo-Olivas M; Mazzetti P; Godeiro C; Vargas FR; Lima MA; van der Linden H; Toralles MB; Medeiros PF; Ribeiro E; Braga-Neto P; Salarini D; Castilhos RM; Saraiva-Pereira ML; Jardim LB;
    Cerebellum; 2015 Dec; 14(6):728-30. PubMed ID: 25869926
    [No Abstract]   [Full Text] [Related]  

  • 10. The parkinsonian phenotype of spinocerebellar ataxia type 2.
    Lu CS; Wu Chou YH; Kuo PC; Chang HC; Weng YH
    Arch Neurol; 2004 Jan; 61(1):35-8. PubMed ID: 14732617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Forces Related to Spinocerebellar Ataxia Type 2.
    Sena LS; Castilhos RM; Mattos EP; Furtado GV; Pedroso JL; Barsottini O; de Amorim MMP; Godeiro C; Pereira MLS; Jardim LB
    Cerebellum; 2019 Apr; 18(2):188-194. PubMed ID: 30219976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progression rate of spinocerebellar ataxia type 2 changes with stage of disease.
    Monte TL; Reckziegel EDR; Augustin MC; Locks-Coelho LD; Santos ASP; Furtado GV; de Mattos EP; Pedroso JL; Barsottini OP; Vargas FR; Saraiva-Pereira ML; Camey SA; Leotti VB; Jardim LB;
    Orphanet J Rare Dis; 2018 Jan; 13(1):20. PubMed ID: 29370806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCA2 in the Indian population: Unified haplotype and variable phenotypic patterns in a large case series.
    Sonakar AK; Shamim U; Srivastava MP; Faruq M; Srivastava AK
    Parkinsonism Relat Disord; 2021 Aug; 89():139-145. PubMed ID: 34298214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
    Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
    Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous ALS and SCA2 associated with an intermediate-length
    Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
    Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
    Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
    Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advance in research on spinocerebellar ataxia 2].
    Jing F; Yang D; Chen T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):284-287. PubMed ID: 29653012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
    Furtado S; Payami H; Lockhart PJ; Hanson M; Nutt JG; Singleton AA; Singleton A; Bower J; Utti RJ; Bird TD; de la Fuente-Fernandez R; Tsuboi Y; Klimek ML; Suchowersky O; Hardy J; Calne DB; Wszolek ZK; Farrer M; Gwinn-Hardy K; Stoessl AJ
    Mov Disord; 2004 Jun; 19(6):622-9. PubMed ID: 15197699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.